Dow Down 0.13% Nasdaq Down 0.04%

Relypsa, Inc. (RLYP)

-NasdaqGS
16.18 Down 0.01(0.06%) 11:26AM EDT - Nasdaq Real Time Price
Prev Close:16.19
Open:16.34
Bid:16.32 x 100
Ask:16.33 x 400
1y Target Est:31.33
Beta:N/A
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:15.98 - 16.56
52wk Range:10.26 - 37.45
Volume:714,334
Avg Vol (3m):2,464,640
Market Cap:724.02M
P/E (ttm):N/A
EPS (ttm):-4.84
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
RLYPDown 0.06%724.02M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-5.91
Quarterly EPS Est (Jun-16) :-1.52
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-1.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Relypsa, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of polymeric medicines for patients with conditions that are overlooked and undertreated and can be addressed in the gastrointestinal tract pr... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback